---
$id: https://graph.org.ai/products/commodity/51282507
$type: Product
source: UNSPSC
code: "51282507"
title: "Cefroxadine"
class: "51282500"
classTitle: "First generation cephalosporins"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cefroxadine

**UNSPSC Code**: 51282507
**Class**: [First generation cephalosporins](First generation cephalosporins.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cephalosporin antibiotic with the molecular formula C16H19N3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B908C4MV2R, chemically known as 7-(d-2-amino-2-(1,4-cyclohexadienyl)acetamide)-3-methoxy-3-cephem-4-carboxylic acid but generally known as cefroxadine, which bears US NIH Compound Identifier 40117. European Medicines Agency schedules Cefroxadine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07419MIG. The term CEFROXADINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). World Health Organization schedules cefroxadine in its Anatomical Therapeutic Chemical (ATC) Classification. CEFROXADINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cefroxadine under HS 29419000 and SITC 54139. As of Q4 2014, CEFROXADINE remains the US FDA Preferred Term for this commodity. Cefroxadine bears US NLM identifiers UMLS ID C0108941 and NCI Concept Code C81033. SMILES: S1C2N(C(=O)C2NC(=O)C(N)C2C=CCC=C2)C(=C(OC)C1)C(=O)O.

